Variant report

Variant	esv3521561
Chromosome Location	chr14:105292357-105294555
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:31)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:31 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr14:105280966..105282808-chr14:105292129..105294295,2	K562	blood:
2	chr14:105292002..105293559-chr14:105403118..105405949,2	MCF-7	breast:
3	chr14:105280954..105282466-chr14:105292119..105293629,2	K562	blood:
4	chr14:105293283..105294221-chr14:105511851..105512622,2	MCF-7	breast:
5	chr14:105268427..105271161-chr14:105291567..105294333,2	K562	blood:
6	chr14:105233810..105238299-chr14:105291361..105295745,6	K562	blood:
7	chr14:105189826..105192403-chr14:105291424..105294271,3	MCF-7	breast:
8	chr14:105292149..105293877-chr14:105432490..105434872,2	MCF-7	breast:
9	chr14:105218306..105221418-chr14:105291704..105295058,3	MCF-7	breast:
10	chr14:105226070..105227570-chr14:105291620..105294600,2	MCF-7	breast:
11	chr14:105293691..105294557-chr14:105406827..105407640,3	MCF-7	breast:
12	chr14:105264645..105268219-chr14:105292165..105294813,6	K562	blood:
13	chr14:105214906..105217436-chr14:105291555..105293979,2	K562	blood:
14	chr14:105234738..105235318-chr14:105293407..105294201,2	K562	blood:
15	chr14:105289983..105292400-chr14:105295807..105297431,2	MCF-7	breast:
16	chr14:105287225..105290811-chr14:105291462..105294551,5	K562	blood:
17	chr14:105234529..105236014-chr14:105292452..105293414,8	MCF-7	breast:
18	chr14:105293628..105294624-chr14:105337330..105337838,2	MCF-7	breast:
19	chr14:105189504..105190527-chr14:105292721..105293350,3	MCF-7	breast:
20	chr14:105190468..105192484-chr14:105291233..105293061,2	MCF-7	breast:
21	chr14:105292450..105295087-chr14:105329500..105333525,7	MCF-7	breast:
22	chr14:105235443..105237438-chr14:105291289..105294293,4	K562	blood:
23	chr14:105292878..105295272-chr14:105309126..105311348,2	MCF-7	breast:
24	chr14:105234486..105235367-chr14:105292449..105293276,4	MCF-7	breast:
25	chr14:105292163..105294059-chr14:105311800..105314620,2	K562	blood:
26	chr14:105294072..105294589-chr14:105362751..105363336,2	MCF-7	breast:
27	chr14:105282552..105286026-chr14:105289483..105293569,5	K562	blood:
28	chr14:105291374..105295422-chr14:105328190..105336195,18	MCF-7	breast:
29	chr14:105214906..105218911-chr14:105291555..105293979,3	K562	blood:
30	chr14:105234590..105235623-chr14:105292148..105293402,8	K562	blood:
31	chr14:105290213..105292759-chr8:144821047..144823089,2	MCF-7	breast:

No data

Variant related genes	Relation type
ENSG00000258430	chromatin interactions
ENSG00000099814	chromatin interactions
ENSG00000184990	chromatin interactions
ENSG00000258701	chromatin interactions
ENSG00000185100	chromatin interactions
ENSG00000179627	chromatin interactions
ENSG00000203499	chromatin interactions

Extended variants
information (count: 70 )
Associated
traits (count: 106 )

Variant overlapped rSNPs/rCNVs (count:70 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs187327548	chr14:105292380-105292381	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
2	rs549251112	chr14:105292392-105292393	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
3	rs369885180	chr14:105292405-105292406	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
4	rs566075902	chr14:105292409-105292410	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
5	rs534888160	chr14:105292415-105292416	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
6	rs12891602	chr14:105292434-105292435	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
7	rs551901910	chr14:105292477-105292478	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
8	rs371643282	chr14:105292546-105292547	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
9	rs76626126	chr14:105292573-105292574	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
10	rs557194369	chr14:105292608-105292609	Bivalent/Poised TSS Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers	Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
11	rs67906390	chr14:105292650-105292651	Bivalent/Poised TSS Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers	Chromatin interactive region	7 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
12	rs536678129	chr14:105292652-105292653	Bivalent/Poised TSS Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers	Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
13	rs553294015	chr14:105292656-105292657	Bivalent/Poised TSS Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers	Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
14	rs377251134	chr14:105292657-105292658	Bivalent/Poised TSS Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers	Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
15	rs573220443	chr14:105292666-105292667	Bivalent/Poised TSS Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers	Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
16	rs147268612	chr14:105292713-105292714	Bivalent/Poised TSS Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers	Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
17	rs545331635	chr14:105292733-105292734	Bivalent/Poised TSS Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers	Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
18	rs565056704	chr14:105292737-105292738	Bivalent/Poised TSS Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers	Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
19	rs56317173	chr14:105292771-105292772	Bivalent/Poised TSS Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
20	rs544273881	chr14:105292775-105292776	Bivalent/Poised TSS Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
21	rs560856128	chr14:105292809-105292810	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
22	rs529634633	chr14:105292871-105292872	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
23	rs56000079	chr14:105292883-105292884	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
24	rs559718257	chr14:105292955-105292956	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
25	rs528717222	chr14:105292967-105292968	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
26	rs551801669	chr14:105292976-105292977	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
27	rs73350382	chr14:105292978-105292979	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
28	rs542263285	chr14:105292994-105292995	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
29	rs544606913	chr14:105293019-105293020	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
30	rs559819314	chr14:105293038-105293039	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
31	rs200583895	chr14:105293177-105293178	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
32	rs12323856	chr14:105293185-105293186	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
33	rs537273676	chr14:105293307-105293308	Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
34	rs377100518	chr14:105293360-105293361	Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
35	rs572247140	chr14:105293475-105293476	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
36	rs541022344	chr14:105293480-105293481	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
37	rs73350383	chr14:105293497-105293498	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
38	rs184695073	chr14:105293534-105293535	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
39	rs536643651	chr14:105293559-105293560	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
40	rs188465925	chr14:105293570-105293571	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
41	rs573289965	chr14:105293573-105293574	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
42	rs538909589	chr14:105293582-105293583	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
43	rs558607462	chr14:105293594-105293595	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
44	rs369417985	chr14:105293668-105293669	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
45	rs544120117	chr14:105293718-105293719	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
46	rs376284050	chr14:105293770-105293771	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
47	rs373326006	chr14:105293785-105293786	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
48	rs561037324	chr14:105293837-105293838	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
49	rs574149998	chr14:105293849-105293850	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
50	rs564166184	chr14:105293884-105293885	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:106)

Disease	PMID	Source
Esophageal cancer	21851588	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Retinoblastoma	21504564	CNVD
High-proliferative meningiomas	17937814	CNVD
Non-small cell lung cancer	21044232	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Melanoma	18172304	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Medulloblastoma	21979893	CNVD
Oral cancer	21386901	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Hepatocellular carcinoma	22174799	CNVD
Neuroblastoma	19435921	CNVD
Colorectal cancer	19359472	CNVD
Breast cancer	17899364	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Renal cell carcinoma	21668985	CNVD
Chronic myeloid leukemia	20724749	CNVD
Wilms tumour	21544195	CNVD
Lung cancer	18438408	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Colorectal cancer	16774939	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Neuroblastoma	18923191	CNVD
Barrett''s syndrome	19417022	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
cataract	16735990	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
small cell lung cancer	20016488	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Developmental delay	21147756	CNVD
Cancer	20164920	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Biliary cancer	19435499	CNVD
Follicular lymphoma	20505157	CNVD
Acute lymphoblastic leukemia	20139093	CNVD
Hepatocellular carcinoma	16750200	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Glioblastoma multiforme	21922591	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Ovarian cancer	22174824	CNVD
Non-small cell lung cancer	18320023	CNVD
Melanoma	17363583	CNVD
Prostate cancer	18632612	CNVD
Congenital heart defect	22367666	CNVD
Developmental delay	22367666	CNVD
Genitourinary abnormalities	22367666	CNVD
Intellectual disability	22367666	CNVD
Microcephaly	22367666	CNVD
Muscularhypotonia	22367666	CNVD
Ocular coloboma	22367666	CNVD
Teratozoospermia	22367666	CNVD
Cervical cancer	21062161	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Breast cancer	21990379	CNVD
Breast cancer	16417655	CNVD
22q11 deletion syndrome	22511897	CNVD
Cancer	21129771	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	22286061	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Schizophrenia	21399695	CNVD
Intracranial ependymoma	16609018	CNVD
Lung adenocarcinoma	17086460	CNVD
Gastric adenocarcinoma	19115996	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
14q deletion syndrome	22511897	CNVD
Epilepsy	22083797	CNVD
Urothelial carcinoma	21177765	CNVD
Ovarian cancer	21720365	CNVD
Cancer	17440070	CNVD
Neurocytoma	17123091	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Central neurocytomas	17123091	CNVD
Acute lymphoblastic leukemia	17315016	CNVD
Lung cancer	17086460	CNVD
Mortal	21835882	CNVD
Breast cancer	21364760	CNVD
small cell lung cancer	17426248	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Schizophrenia	20967226	CNVD
Non-syndromic sensorineural hearing loss	19587683	CNVD
early-passage human iPS cells	21368824	CNVD
Williams Syndrome	20824207	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Pancreatic cancer	17952125	CNVD
Schizophrenia	23813976	CNVD
lymphocytic leukemia	21291569	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:497 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr14:105287200-105292600	Weak transcription	HSMMtube	muscle
2	chr14:105291000-105292800	Enhancers	Primary T killer memory cells from peripheral blood	blood
3	chr14:105291800-105292400	Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
4	chr14:105291800-105294400	Enhancers	Spleen	Spleen
5	chr14:105292000-105292400	Bivalent/Poised TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
6	chr14:105292000-105292400	Bivalent/Poised TSS	iPS DF 6.9 Cell Line	embryonic stem cell
7	chr14:105292000-105292400	Flanking Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
8	chr14:105292000-105292400	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
9	chr14:105292000-105292400	Active TSS	ES-UCSF4 Cell Line	embryonic stem cell
10	chr14:105292000-105292400	Flanking Active TSS	Breast Myoepithelial Primary Cells	Breast
11	chr14:105292000-105292400	Flanking Active TSS	Primary T helper cells PMA-I stimulated	--
12	chr14:105292000-105292400	Enhancers	Primary T killer naive cells fromperipheralblood	blood
13	chr14:105292000-105292400	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
14	chr14:105292000-105292400	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
15	chr14:105292000-105292400	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
16	chr14:105292000-105292400	Flanking Active TSS	Foreskin Melanocyte Primary Cells skin01	Skin
17	chr14:105292000-105292400	Flanking Active TSS	Foreskin Melanocyte Primary Cells skin03	Skin
18	chr14:105292000-105292400	Enhancers	Aorta	Aorta
19	chr14:105292000-105292400	Bivalent/Poised TSS	Brain Germinal Matrix	brain
20	chr14:105292000-105292400	Flanking Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
21	chr14:105292000-105292400	Flanking Active TSS	Colonic Mucosa	Colon
22	chr14:105292000-105292400	Flanking Bivalent TSS/Enh	Fetal Lung	lung
23	chr14:105292000-105292400	Bivalent Enhancer	Fetal Thymus	thymus
24	chr14:105292000-105292400	Enhancers	Pancreas	Pancrea
25	chr14:105292000-105292400	Flanking Active TSS	Rectal Mucosa Donor 29	rectum
26	chr14:105292000-105292400	Flanking Active TSS	Right Atrium	heart
27	chr14:105292000-105292400	Flanking Active TSS	Right Ventricle	heart
28	chr14:105292000-105292400	Flanking Bivalent TSS/Enh	Skeletal Muscle Male	skeletal muscle
29	chr14:105292000-105292400	Flanking Bivalent TSS/Enh	Skeletal Muscle Female	skeletal muscle
30	chr14:105292000-105292400	Bivalent Enhancer	Stomach Mucosa	stomach
31	chr14:105292000-105292800	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
32	chr14:105292000-105292800	Flanking Active TSS	IMR90 fetal lung fibroblasts Cell Line	lung
33	chr14:105292000-105292800	Flanking Bivalent TSS/Enh	Primary T cells fromperipheralblood	blood
34	chr14:105292000-105292800	Flanking Active TSS	Primary T helper naive cells fromperipheralblood	blood
35	chr14:105292000-105292800	Flanking Active TSS	Primary T helper 17 cells PMA-I stimulated	--
36	chr14:105292000-105292800	Flanking Active TSS	Primary T helper cells fromperipheralblood	blood
37	chr14:105292000-105292800	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells G-CSF-mobilized Female	--
38	chr14:105292000-105292800	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells G-CSF-mobilized Male	--
39	chr14:105292000-105292800	Flanking Active TSS	Muscle Satellite Cultured Cells	--
40	chr14:105292000-105292800	Flanking Active TSS	Cortex derived primary cultured neurospheres	brain
41	chr14:105292000-105292800	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
42	chr14:105292000-105292800	Flanking Active TSS	Adipose Nuclei	Adipose
43	chr14:105292000-105292800	Flanking Bivalent TSS/Enh	Fetal Adrenal Gland	Adrenal Gland
44	chr14:105292000-105292800	Flanking Bivalent TSS/Enh	Fetal Muscle Trunk	muscle
45	chr14:105292000-105292800	Flanking Active TSS	Placenta	Placenta
46	chr14:105292000-105292800	Flanking Active TSS	Stomach Smooth Muscle	stomach
47	chr14:105292000-105292800	Flanking Active TSS	HMEC	breast
48	chr14:105292000-105292800	Flanking Bivalent TSS/Enh	Monocytes-CD14+_RO01746	blood
49	chr14:105292000-105293400	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
50	chr14:105292000-105293400	Active TSS	NHEK	skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links